{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:03:45Z","timestamp":1784271825704,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jdcr.2026.04.024","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:02:26Z","timestamp":1776783746000},"page":"8-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Alopecia areata during dupilumab therapy: 2 cases and review of the literature"],"prefix":"10.1016","volume":"73","author":[{"given":"Amnah Nasser","family":"Almulhim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeel Khalid","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad Mohammad","family":"Alfehaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jury Waleed","family":"Albaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad","family":"Almakhaitah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenah Yassir","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2026.04.024_bib1","series-title":"StatPearls [Internet]","article-title":"Alopecia areata","author":"Lepe","year":"2025"},{"issue":"8","key":"10.1016\/j.jdcr.2026.04.024_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13899","article-title":"Dupilumab: mechanism of action, clinical, and translational science","volume":"17","author":"McCann","year":"2024","journal-title":"Clin Transl Sci"},{"issue":"1","key":"10.1016\/j.jdcr.2026.04.024_bib3","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jisp.2020.04.007","article-title":"Alopecia areata: a complex cytokine driven disease","volume":"20","author":"Song","year":"2020","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jdcr.2026.04.024_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jdcr.2025.05.048","article-title":"A case series of dupilumab for vitiligo and alopecia areata in the setting of atopic dermatitis","volume":"64","author":"Patel","year":"2025","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2026.04.024_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1395288","article-title":"Case report: sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children","volume":"15","author":"Fang","year":"2024","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jdcr.2026.04.024_bib6","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/jvc2.70150","article-title":"Successful treatment of coexisting alopecia areata and bullous pemphigoid with dupilumab: a case report","volume":"4","author":"Brinks","year":"2025","journal-title":"JEADV Clin Pract"},{"issue":"9","key":"10.1016\/j.jdcr.2026.04.024_bib7","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1111\/1346-8138.14880","article-title":"Case of alopecia areata during dupilumab treatment for atopic dermatitis","volume":"46","author":"Kanda","year":"2019","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2026.04.024_bib8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.18176\/jiaci.0301","article-title":"Alopecia areata in severe atopic dermatitis treated with dupilumab","volume":"28","author":"Barroso-Garcia","year":"2018","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1S","key":"10.1016\/j.jdcr.2026.04.024_bib9","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/DER.0000000000000512","article-title":"Reactivation of Alopecia areata after dupilumab therapy for atopic dermatitis","volume":"32","author":"Carnicle","year":"2021","journal-title":"Dermatitis"},{"issue":"5","key":"10.1016\/j.jdcr.2026.04.024_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1684\/ejd.2019.3626","article-title":"Early onset of alopecia areata after dupilumab introduction in a patient with atopic dermatitis","volume":"29","author":"Barbarin","year":"2019","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2026.04.024_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jdcr.2018.10.010","article-title":"Drug-induced alopecia after dupilumab therapy","volume":"5","author":"Flanagan","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"8","key":"10.1016\/j.jdcr.2026.04.024_bib12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jdcr.2019.03.019","article-title":"Alopecia areata in 2 patients treated with dupilumab: new onset and worsening","volume":"5","author":"Chung","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"2","key":"10.1016\/j.jdcr.2026.04.024_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jdcr.2017.11.020","article-title":"Alopecia areata after dupilumab for atopic dermatitis","volume":"4","author":"Mitchell","year":"2018","journal-title":"JAAD Case Rep"},{"issue":"3","key":"10.1016\/j.jdcr.2026.04.024_bib14","first-page":"e41","article-title":"Dermatitis and alopecia in a patient treated with dupilumab: a new adverse effect?","volume":"44","author":"Salguero-Fernandez","year":"2019","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2026.04.024_bib15","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.abd.2021.03.005","article-title":"Alopecia areata-like and psoriasis after dupilumab use for atopic dermatitis","volume":"96","author":"Maiolini","year":"2021","journal-title":"An Bras Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2026.04.024_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12869","article-title":"Development of alopecia in patients treated with dupilumab","volume":"32","author":"Maloney","year":"2019","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jdcr.2026.04.024_bib17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaad.2025.05.1387","article-title":"Friend or foe: a systematic review of dupilumab and alopecia areata","volume":"93","author":"Srivatsa","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"14","key":"10.1016\/j.jdcr.2026.04.024_bib18","first-page":"1","article-title":"Alopecia areata associated with dupilumab: national database study","volume":"15","author":"Sontam","year":"2025","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.jdcr.2026.04.024_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.25259\/IJDVL_1388_2023","article-title":"A novel mutation in autoimmune polyglandular syndrome type 1 with erythematous facial papules","volume":"91","author":"Saha","year":"2025","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1016\/j.jdcr.2026.04.024_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaad.2023.05.025","article-title":"Letter from the editor: paradoxical reactions to biologics","volume":"90","author":"Elston","year":"2024","journal-title":"J Am Acad Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626002249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626002249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:15:33Z","timestamp":1784268933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626002249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":20,"alternative-id":["S2352512626002249"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.04.024","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alopecia areata during dupilumab therapy: 2 cases and review of the literature","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}